Yimaikang Dispersible Tablets
Function and Efficacy
The results of animal experiments indicate that this product can reduce the malondialdehyde (MDA) content and increase the activity of superoxide dismutase (SOD) in rabbits with chronic intraocular hypertension; reduce the permeability of retinal blood vessels; and increase the grayscale of retinal ganglion cells with high cytochrome oxidase activity and the density of active ganglion cells in rats with acute intraocular hypertension.
Ingredients
Eupatorium wilfordii.
Appearance
This product is light gray-yellow tablets; tastes slightly bitter.
Usage and Dosage
Oral administration, 2 tablets at a time, three times a day.
Adverse Reactions
Not yet clear.
Precautions
Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed. Store in a cool, dry place.
Packaging Specification
Each tablet weighs 0.4g (containing 40mg total flavonoids)
Validity Period
24 months
Manufacturer
Hunna Xiangya Pharmaceutical Co., Ltd.
-
Founded in:
1993-05-26 -
Address:
No. 199, Yinshuang Road, Yuelu District, Changsha -
Tax NO.:
914300006166067801 -
Registered Funds:
29.225 million yuan -
Website:
-
Email: